Navigation Links
Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDC's Advisory Committee on Immunization Practices
Date:6/24/2009

- Expanded Guidelines to include availability of IXIARO(R) vaccine for Japanese Encephalitis

- IXIARO now available in the U.S. for travelers to Asia, military personnel, others at high risk regardless of the length of visit

ATLANTA, June 24 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to update its previous recommendations and include IXIARO, a new Japanese Encephalitis (JE) vaccine for travelers to countries in Asia where the disease is endemic, as well as Americans living in such high-risk areas.

ACIP made significant changes to their previous Japanese Encephalitis recommendations, last updated in 1993, noting that many more travelers are now visiting areas where the disease is endemic. In addition to recognizing the recent licensure of IXIARO, the committee's expanded recommendations urged clinicians to consider vaccinating travelers visiting endemic areas during the transmission season, even those on short-term visits, if they plan to spend a substantial amount of time outdoors. The panel also concluded that IXIARO, which is derived from a well-established cell line and does not contain stabilizers or preservatives, has a lower risk of vaccine-associated adverse events than older Japanese Encephalitis vaccines.

IXIARO received marketing approval from the U.S. Food and Drug Administration on March 30, 2009 on the basis of studies that showed the vaccine is highly immunogenic after only two doses. IXIARO has been shown to stimulate a long-lasting immune response and to be well tolerated. It is the only currently manufactured Japanese Encephalitis vaccine available in the United States. IXIARO was developed by Intercell AG; the rights to market and distribute the vaccine to the private sector in the United States are held by Novartis Vaccines.


'/>"/>
SOURCE Intercell AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Intercell to Webcast Research & Development Day on Thursday, June 4, 2009
2. Intercell Executes Multi-Year Contract for Supply of IXIARO(R) to the United States Military
3. Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
4. Helicobacter pylori inhibits intercellular communication of cultured gastric cells
5. Greenway Medical Technologies Supports Community-Based Interoperability Efforts by Offering Preferred Rates to Buffalo, N.Y. Area Community Healthcare Organizations
6. Satellite Healthcare Supports Kidney Wellness in Chicago
7. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
8. Lifeclinic Supports Healthy Workforce and Health Promotion First Acts
9. Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans
10. American College of Surgeons Supports Bill to Create New Frontline Providers Loan Repayment Program
11. Study supports validity of test that indicates widespread unconscious bias
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... three Ebola cases in Dallas. But, mental health specialists say ... President Barack Obama on Friday appointed an Ebola "czar" ... infected two Dallas nurses who cared for a Liberian man ... Hospital. But the U.S. cases are miniscule in the ...
(Date:10/22/2014)... Los Angeles, California (PRWEB) October 22, 2014 ... Recovery 2.0: Move Beyond Addiction and Upgrade Your Life (Paperback; ... the field of Yoga & Recovery. This book is ... and thrive in a life of recovery. , Recovery ... of the 12 Steps; Recovery 2.0 is a guide for ...
(Date:10/22/2014)... October 22, 2014 Healthcare professionals ... their continuing education at home or on-the-go via ... to 20 brand new, premium Seminar-on-Demand CE courses. ... of over 2,000 hours of CE ... their educational experience. With such a diverse library, ...
(Date:10/22/2014)... 22, 2014 Richard Carlson, Managing Partner ... leader with over 25 years experience. Mr. Carlson ... the areas related to EDI, B2B Commerce, RFID and ... Editorial Advisory Board member for Pharmaceutical Commerce Magazine and ... Fin Group is a management and technology consulting firm ...
(Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Two sisters in ... heart damage. Ilina and Medha Krishen use electronic ... sounds of trouble in breathing patterns or heartbeats. ... in Michigan, wanted to find a way to detect ... pollutants. Using an electronic stethoscope, Ilina recorded one breath ...
Breaking Medicine News(10 mins):Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... in which blood glucose levels are above normal. People ... is broken down into a sugar called glucose, which ... body. Cells use the hormone insulin, made in the ... People with diabetes can prevent or delay complications by ...
... women with diabetes should not take hormone replacement therapy. Researchers ... take HRT increase their chances of dying early. Researchers also ... heart disease or having a heart attack. They studied 13,084 ... whom had taken HRT. They found that women with diabetes ...
... the SARS virus could be stopped and could be treated. ... said the average daily new cases had dropped by more ... this assurance as he was treating three foreigners, two from ... ,He said the number of cases of Severe Acute ...
... Medical School has shown that Men who smoke more than 20 ... caused by bleeding into the brain. Researchers had already identified a ... blood vessel serving the brain - and smoking. The new study ... has shown that compared to those who// had never smoked, men ...
... A new study by researchers at the A & A ... pain reduction & Algology: the study of pain), have,found that ... by cancer. In a study of seven patients between 39 ... is caused by the tumor pressing on,the nerve, analgesic drugs ...
... have reported in the British,Medical Journal that fathers might ... or 294 days. The condition of prolonged pregnancies affects,around ... of about 28,000,women between 1980 and 1994. About 21,000 ... lasted longer than 42 weeks and another 7,000 women ...
Cached Medicine News:
(Date:10/22/2014)... Influenza will affect as many as 200,000 people this year ... as high as 49,000 people.  The main way ... to person in respiratory droplets of coughs and sneezes. ... kills much fewer people each year than the Flu. The ... sweat, saliva, blood and other bodily fluids. The Ebola virus ...
(Date:10/22/2014)... -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) – According ... Data Services, demand for thermometers is expected to grow ... demand for more accurate digital thermometers continues.  ... market for thermometers, and one of the companies serving ... Inc. Sanomedics International Holdings designs, develops, markets, ...
(Date:10/22/2014)... YORK , Oct. 22, 2014 Provectus ... dermatology therapies. PV-10, its novel investigational drug for cancer, ... potential for systemic side effects. Its oncology focus is ... Provectus has completed phase 2 trials of PV-10 as ... a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... The Society for Biomolecular Sciences, now officially the ... and Screening (SLAS), invites students, graduate students, post-doctoral associates ... Travel Award to be used for the SBS 17th ... FL, USA. Applicants must be the primary ...
... Nov. 4, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Conference in Phoenix, Arizona on Thursday, November 11, 2010 at ... M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, ... be webcast live through the "Investors" section of Amylin,s corporate ...
Cached Medicine Technology:Applications Now Being Accepted for SBS 17th Annual Conference & Exhibition Academic Travel Awards 2
...
... on decades of experience, the SSD-1000 is ... system. It uses our advanced technologies and ... Using the same technology as our more ... capabilities in a compact and mobile setting., ...
... Harmonic Echo technology constructs images using ... less artifacts and noise than fundamental-frequency ... technology to transmit distortion-free, fundamental-frequency ultrasound ... beam is a pure sinusoidal wave, ...
... Topical Skin Adhesive gives you new options ... intended for topical application only to hold ... from surgical incisions, including punctures from minimally ... lacerations. DERMABOND adhesive may be used in ...
Medicine Products: